deserves further clinical investigation.As stated in the title, this article merely records our clinical impressions of surital.At present a com- parable pentothal series is being conducted and it is hoped at a later date to publish an accurate comparison of these two agents.SUMMARY A new thiobarbiturate for intravenous anaesthesia has been discussed.Its use in 490 cases involving a wide variety of techniques has been described.Decreased respiratory depression, laryngospasm and circulatory depression, increased potency and more rapid recovery, are its ap- parent advantages over intravenous barbiturates in current use.Complications and contra-indications are the same as for pentothal.The advantages displayed by this agent entitle it to further clinical trial.
No takes yet. Share an insight, caveat, or question.
John R. Wood (1950) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: